Crystal structure of an inhibitor complex of Aurora A kinase and preliminary in vitro SAR analysis of quinazoline inhibitors.

被引:0
|
作者
Keen, N
Anderson, M
Valentine, A
McMiken, H
Tucker, J
Rowsetl, S
Pannifer, A
Pauptit, R
Mortlock, A
Heron, N
Green, S
Jung, F
机构
[1] AstraZeneca, Alderley Pk, Cheshire, England
[2] AstraZeneca, Reims, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:6217S / 6218S
页数:2
相关论文
共 50 条
  • [1] SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors
    Heron, NM
    Anderson, M
    Blowers, DP
    Breed, J
    Eden, JM
    Green, S
    Hill, GB
    Johnson, T
    Jung, FH
    McMiken, HHJ
    Mortlock, AA
    Pannifer, AD
    Pauptit, RA
    Pink, J
    Roberts, NJ
    Rowsell, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1320 - 1323
  • [2] Discovery, synthesis, SAR, and in vitro/in vivo characterization of a novel quinolinone class of VEGFR-2 (KDR) kinase inhibitors.
    Fraley, ME
    Antanavage, J
    Arrington, KL
    Ciecko, PA
    Coll, KE
    Gibbs, JB
    Hambaugh, SR
    Hartman, GD
    Heimbrook, DC
    Hoffman, WF
    Hungate, RW
    Kohl, NE
    Mao, XZ
    McFall, RC
    Rands, E
    Rickert, K
    Sepp-Lorenzino, L
    Shipman, JM
    Tebben, AJ
    Thomas, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U44 - U45
  • [3] Applications of sensitivity analysis and comparative sequence/structure analysis to designing specific protein kinase inhibitors.
    Wong, CF
    McCammon, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U468 - U468
  • [4] Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
    Bullock, Alex N.
    Russo, Santina
    Amos, Ann
    Pagano, Nicholas
    Bregman, Howard
    Debreczeni, Judit E.
    Lee, Wen Hwa
    von Delft, Frank
    Meggers, Eric
    Knapp, Stefan
    PLOS ONE, 2009, 4 (10):
  • [5] Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680
    Young, MA
    Shah, NP
    Chao, LH
    Seeliger, M
    Milanov, ZV
    Biggs, WH
    Treiber, DK
    Patel, HK
    Zarrinkar, PP
    Lockhart, DVJ
    Sawyers, CL
    Kuriyan, J
    CANCER RESEARCH, 2006, 66 (02) : 1007 - 1014
  • [6] Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone scaffold:: Analysis of X-ray crystal structure of enzyme inhibitor complex
    Nilsson, JW
    Kvarnström, I
    Musil, D
    Nilsson, I
    Samulesson, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) : 3985 - 4001
  • [7] Development of selective RabGGTase inhibitors and crystal structure of a RabGGTase-inhibitor complex
    Guo, Zhong
    Wu, Yao-Wen
    Tan, Kui-Thong
    Bon, Robin S.
    Guiu-Rozas, Ester
    Delon, Christine
    Nguyen, Uyen T.
    Wetzel, Stefan
    Arndt, Sabine
    Goody, Roger S.
    Blankenfeldt, Wulf
    Alexandrov, Kirill
    Waldmann, Herbert
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (20) : 3747 - 3750
  • [8] Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects
    Mettey, Y
    Gompel, M
    Thomas, V
    Garnier, M
    Leost, M
    Ceballos-Picot, I
    Noble, M
    Endicott, J
    Vierfond, JM
    Meijer, L
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) : 222 - 236
  • [9] Identification, SAR Studies, and X-ray Co-crystallographic Analysis of a Novel Furanopyrimidine Aurora Kinase A Inhibitor
    Coumar, Mohane Selvaraj
    Tsai, Ming-Tsung
    Chu, Chang-Ying
    Uang, Biing-Jiun
    Lin, Wen-Hsing
    Chang, Chun-Yu
    Chang, Teng-Yuan
    Leou, Jiun-Shyang
    Teng, Chi-Huang
    Wu, Jian-Sung
    Fang, Ming-Yu
    Chen, Chun-Hwa
    Hsu, John T-A
    Wu, Su-Ying
    Chao, Yu-Sheng
    Hsieh, Hsing-Pang
    CHEMMEDCHEM, 2010, 5 (02) : 255 - 267